HTG Molecular Diagnostics | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
HTG Molecular Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Barat Stephen
HTG Molecular Diagnostics | 8-K: Current report
HTG Molecular Diagnostics | 8-K: HTG Molecular Diagnostics Files for Bankruptcy and Terminates Byron T. Lawson, Senior Vice President and Chief Commercial Officer
HTG Molecular Diagnostics | 8-K: Current report
HTG Molecular Diagnostics | 8-K: Drug Discovery Engine Highlights
HTG Molecular Diagnostics | 10-Q: Q1 2023 Earnings Report
HTG Molecular Diagnostics: Htg Molecular Diagnostics Reports First Quarter 2023 Results And Provides Recent Business Highlights
8-K | HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Filer)
HTG Molecular Diagnostics | 8-K: Update on Drug Discovery Partnering Initiative
HTG Molecular Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Barat Stephen
HTG Molecular Diagnostics: FY2022 Annual Report
10-K | HTG MOLECULAR DIAGNOSTICS, INC (0001169987) (Filer)
HTG Molecular Diagnostics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Laurence W. Lytton(0%)
HTG Molecular Diagnostics | 3: Initial statement of beneficial ownership of securities-Officer Barat Stephen
HTG Molecular Diagnostics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Samjo Management, LLC(0%),Andrew N. Wiener(0%), etc.
HTG Molecular Diagnostics | 8-K: First-Half 2023 Corporate Goals
HTG Molecular Diagnostics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cowen Prime Advisors LLC(0%)
HTG Molecular Diagnostics | 8-K: HTG Molecular Diagnostics Announces Certain Preliminary 2022 Unaudited Financial Results
HTG Molecular Diagnostics | 8-K: HTG Molecular Diagnostics has regained compliance with the Nasdaq Stock Market Rule 5550(b)
HTG Molecular Diagnostics | 8-K: HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering
HTG Molecular Diagnostics | 424B4: Prospectus
No Data